63 related articles for article (PubMed ID: 2800821)
21. Comparison of diagnostic tests in myasthenia gravis.
Nicholson GA; McLeod JG; Griffiths LR
Clin Exp Neurol; 1983; 19():45-9. PubMed ID: 6568927
[TBL] [Abstract][Full Text] [Related]
22. Comparison of antigenic sources for acetylcholine receptor antibody assays in myasthenia gravis.
McAdams MW; Roses AD
Ann Neurol; 1980 Jul; 8(1):61-6. PubMed ID: 6773466
[TBL] [Abstract][Full Text] [Related]
23. [Myasthenic syndrome. Diagnostic trends].
Gajdos P
Rev Prat; 2000 Feb; 50(4):419-23. PubMed ID: 10748676
[No Abstract] [Full Text] [Related]
24. Unilateral ocular myasthenia gravis--a case report.
Chouhan JK; Soni TB; Mishra YC
Indian J Ophthalmol; 1990; 38(1):35. PubMed ID: 2365437
[TBL] [Abstract][Full Text] [Related]
25. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
[TBL] [Abstract][Full Text] [Related]
26. Myasthenia gravis mimicking upward gaze palsy without pupillary and palpebral involvement.
Wu HJ; Tsai RK
Jpn J Ophthalmol; 2005; 49(2):181-2. PubMed ID: 15838742
[No Abstract] [Full Text] [Related]
27. Immune regulation in myasthenia gravis: evidence for an increased suppressor T-cell population.
Miller AE; Hudson J; Tindall RS
Ann Neurol; 1982 Oct; 12(4):341-7. PubMed ID: 6216848
[TBL] [Abstract][Full Text] [Related]
28. Immunoregulatory CD8+ cells recognize antigen-activated CD4+ cells in myasthenia gravis patients and in healthy controls.
Yuen MH; Protti MP; Diethelm-Okita B; Moiola L; Howard JF; Conti-Fine BM
J Immunol; 1995 Feb; 154(3):1508-20. PubMed ID: 7529806
[TBL] [Abstract][Full Text] [Related]
29. Open-loop and closed-loop optokinetic nystagmus (OKN) in myasthenia gravis and nonmyasthenic subjects.
Yang Q; Wei M; Sun F; Tian J; Chen X; Lu C
Exp Neurol; 2000 Nov; 166(1):166-72. PubMed ID: 11031092
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.
Tüzün E; Saini SS; Ghosh S; Rowin J; Meriggioli MN; Christadoss P
Neuromuscul Disord; 2006 Feb; 16(2):137-43. PubMed ID: 16427283
[TBL] [Abstract][Full Text] [Related]
31. [Myasthenia with monoclonal kappa IgM gammapathy and presence of anti-striated muscle antibodies].
Modigliani E; Charbord P; Landman C; Delzant G; Faure A; Gattegno L; Cornillot P; Sebaoun J
Ann Med Interne (Paris); 1973 Mar; 124(3):193-200. PubMed ID: 4577478
[No Abstract] [Full Text] [Related]
32. Study of anti-striational and anti-thyroid antibodies in patients with myasthenia gravis.
Cojocaru IM; Cojocaru M; Muşuroi C
Rom J Intern Med; 2000-2001; 38-39():111-20. PubMed ID: 15529579
[TBL] [Abstract][Full Text] [Related]
33. Defective mitogenic responses in myasthenia gravis and multiple sclerosis.
Dropcho EJ; Richman DP; Antel JP; Arnason BG
Ann Neurol; 1982 May; 11(5):456-62. PubMed ID: 6980619
[TBL] [Abstract][Full Text] [Related]
34. [Bulbo-spinal myasthenia acute from the onset. Value of semeiologic analysis of the deficiency of the palpebral orbicular muscles].
Giroire H; Charbonnel A; Baron A; Vercelletto P; Fève JR; Besançon G
Rev Otoneuroophtalmol; 1966; 38(4):196-200. PubMed ID: 5926356
[No Abstract] [Full Text] [Related]
35. [Myasthenia gravis in Santo Tomás Hospital 1990-1997].
Frago G; Gracia F; Chang E; Andrade Alegre R
Rev Med Panama; 1998 Sep; 23(2):15-9. PubMed ID: 11214554
[TBL] [Abstract][Full Text] [Related]
36. Clinical profile of myasthenia gravis in the Sultanate of Oman.
Jacob PC; Tharakan JT; Chand PR; Koul RL; Chacko AP
Saudi Med J; 2003 Jul; 24(7):774-5. PubMed ID: 12883613
[TBL] [Abstract][Full Text] [Related]
37. [Significance of electronystagmography in the diagnosis of myasthenia].
Latkowski B; Rydzewski W
Otolaryngol Pol; 1973; 27(4):493-8. PubMed ID: 4757016
[No Abstract] [Full Text] [Related]
38. [Letter: Diagnosis of myasthenia].
Samland O
Dtsch Med Wochenschr; 1976 Aug; 101(32):1202-3. PubMed ID: 939178
[No Abstract] [Full Text] [Related]
39. The intra-arterial injection of neostigmine as a diagnostic test in myasthenia gravis.
HUTCHINSON EC; MATTHEWS WB
J Neurol Neurosurg Psychiatry; 1953 Feb; 16(1):47-8. PubMed ID: 13023440
[No Abstract] [Full Text] [Related]
40. [Immunologic aspects of myasthenia gravis].
Milohanović S; Jurjević A; Ledić P; Willheim K; Rukavina D
Neurologija; 1979; 27(1-4):163-6. PubMed ID: 262005
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
